Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
MacroGenics (NASDAQ:MGNX – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, May 3rd. Analysts expect the company to announce earnings of ($0.80) per share for the quarter. MacroGenics (NASDAQ:MGNX – Get Rating) last posted its quarterly earnings results on Thursday, February 24th. The biopharmaceutical company reported […]
Wall Street brokerages predict that MacroGenics, Inc. (NASDAQ:MGNX – Get Rating) will post $20.76 million in sales for the current quarter, Zacks reports. Three analysts have issued estimates for MacroGenics’ earnings, with estimates ranging from $17.10 million to $27.87 million. MacroGenics reported sales of $16.88 million in the same quarter last year, which would suggest […]
Shares of MacroGenics, Inc. (NASDAQ:MGNX – Get Rating) hit a new 52-week low during trading on Monday . The company traded as low as $8.02 and last traded at $8.21, with a volume of 48121 shares traded. The stock had previously closed at $8.49. A number of research analysts have recently commented on the company. […]
MacroGenics (NASDAQ:MGNX – Get Rating) had its target price decreased by SVB Leerink from $40.00 to $23.00 in a research report sent to investors on Friday, Analyst Ratings Network reports. SVB Leerink currently has an outperform rating on the biopharmaceutical company’s stock. Several other research analysts have also recently commented on MGNX. BMO Capital Markets […]